Baidu
map

北大一院感染科主任:目前新冠患者复阳比例为5%到15%

2020-05-07 佚名 央视新闻

5月7日,国务院联防联控机制医疗救治专家组成员、科技攻关专家组成员、北京大学第一医院感染疾病科主任王贵强,在国务院联防联控机制举办的新闻发布会上,回答了关于新冠肺炎治愈患者存在复阳风险的问题,并对新冠

5月7日,国务院联防联控机制医疗救治专家组成员、科技攻关专家组成员、北京大学第一医院感染疾病科主任王贵强,在国务院联防联控机制举办的新闻发布会上,回答了关于新冠肺炎治愈患者存在复阳风险的问题,并对新冠肺炎治愈患者提出了提醒和建议。

出院后普通患者需隔离14天,重症患者要密切监测

国务院联防联控机制医疗救治专家组成员、科技攻关专家组成员、北京大学第一医院感染疾病科主任王贵强:病人一般轻型的,普通型的,达到了出院标准,解除隔离之后居家隔离14天,严格按照隔离的要求。包括要求这个病人要单独的房间,要戴口罩,不要和家属密切的接触等等,实际也是防止他可能潜在传播的风险。

对重症、危重症的病人,我们强调出院后一定要密切的监测和随访,因为这里面有些病人有基础病,需要进一步的治疗,有一部分可能存在着肺功能逐渐的恢复,甚至个别的可能会有肺纤维化的发生和发展的问题,所以出院以后对所有病人都要密切的监测随访。我们要求出院两周和四周后都要到医院去复查,包括查肺功能、胸片、血常规等等。也是希望通过出院后的随访,保证这些病人顺利的康复。

不能大意!我国目前复阳率为5%到15%

国务院联防联控机制医疗救治专家组成员、科技攻关专家组成员、北京大学第一医院感染疾病科主任王贵强:对复阳的情况,第一要隔离,因为有传染性的风险。尽管传染性低一些,但是不能说没传染性,要按照传染性来观察。目前看,复阳病例在我国目前初步的数据是5%到15%左右,像武汉地区是6%左右;广东可能高一些;有些地方很低,像上海就百分之零点几,差别比较大。总体复阳人群不是特别高,但是我们要隔离观察。第二个方面,我们对复阳病例要观察临床哪些变化,大部分病人是没有症状的,只有极个别的会出现症状,极少数的会出现肺片,胸片CT上有些肺炎的进展,大部分病人是很稳定的,需要隔离观察就可以了,这部分病人我们还在做研究,到底是免疫功能的问题,还是没检出?有一部分持续阳性,所以这一方面还需要做更多的工作,总体来讲对复阳的病人不能大意,要进行很好的密切检测随访。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1653920, encodeId=067d1653920d1, content=<a href='/topic/show?id=6ca3533593e' target=_blank style='color:#2F92EE;'>#感染科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53359, encryptionId=6ca3533593e, topicName=感染科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d58c24405540, createdName=手留余香, createdTime=Mon Mar 08 13:06:12 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906517, encodeId=4a4d190651e1f, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58057, encryptionId=317e5805e9d, topicName=新冠患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Jun 06 12:06:12 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766545, encodeId=4e7e1e66545e8, content=<a href='/topic/show?id=bc80e48144f' target=_blank style='color:#2F92EE;'>#科主任#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74814, encryptionId=bc80e48144f, topicName=科主任)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f3637838032, createdName=446798725_87912777, createdTime=Sun Jul 05 12:06:12 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604877, encodeId=d8d416048e755, content=<a href='/topic/show?id=42649836582' target=_blank style='color:#2F92EE;'>#院感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98365, encryptionId=42649836582, topicName=院感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003319278834, createdName=ms6390871039024434, createdTime=Sat May 09 13:06:12 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027970, encodeId=a02c102e970a9, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:06:12 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1653920, encodeId=067d1653920d1, content=<a href='/topic/show?id=6ca3533593e' target=_blank style='color:#2F92EE;'>#感染科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53359, encryptionId=6ca3533593e, topicName=感染科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d58c24405540, createdName=手留余香, createdTime=Mon Mar 08 13:06:12 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906517, encodeId=4a4d190651e1f, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58057, encryptionId=317e5805e9d, topicName=新冠患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Jun 06 12:06:12 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766545, encodeId=4e7e1e66545e8, content=<a href='/topic/show?id=bc80e48144f' target=_blank style='color:#2F92EE;'>#科主任#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74814, encryptionId=bc80e48144f, topicName=科主任)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f3637838032, createdName=446798725_87912777, createdTime=Sun Jul 05 12:06:12 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604877, encodeId=d8d416048e755, content=<a href='/topic/show?id=42649836582' target=_blank style='color:#2F92EE;'>#院感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98365, encryptionId=42649836582, topicName=院感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003319278834, createdName=ms6390871039024434, createdTime=Sat May 09 13:06:12 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027970, encodeId=a02c102e970a9, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:06:12 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1653920, encodeId=067d1653920d1, content=<a href='/topic/show?id=6ca3533593e' target=_blank style='color:#2F92EE;'>#感染科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53359, encryptionId=6ca3533593e, topicName=感染科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d58c24405540, createdName=手留余香, createdTime=Mon Mar 08 13:06:12 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906517, encodeId=4a4d190651e1f, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58057, encryptionId=317e5805e9d, topicName=新冠患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Jun 06 12:06:12 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766545, encodeId=4e7e1e66545e8, content=<a href='/topic/show?id=bc80e48144f' target=_blank style='color:#2F92EE;'>#科主任#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74814, encryptionId=bc80e48144f, topicName=科主任)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f3637838032, createdName=446798725_87912777, createdTime=Sun Jul 05 12:06:12 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604877, encodeId=d8d416048e755, content=<a href='/topic/show?id=42649836582' target=_blank style='color:#2F92EE;'>#院感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98365, encryptionId=42649836582, topicName=院感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003319278834, createdName=ms6390871039024434, createdTime=Sat May 09 13:06:12 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027970, encodeId=a02c102e970a9, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:06:12 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1653920, encodeId=067d1653920d1, content=<a href='/topic/show?id=6ca3533593e' target=_blank style='color:#2F92EE;'>#感染科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53359, encryptionId=6ca3533593e, topicName=感染科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d58c24405540, createdName=手留余香, createdTime=Mon Mar 08 13:06:12 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906517, encodeId=4a4d190651e1f, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58057, encryptionId=317e5805e9d, topicName=新冠患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Jun 06 12:06:12 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766545, encodeId=4e7e1e66545e8, content=<a href='/topic/show?id=bc80e48144f' target=_blank style='color:#2F92EE;'>#科主任#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74814, encryptionId=bc80e48144f, topicName=科主任)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f3637838032, createdName=446798725_87912777, createdTime=Sun Jul 05 12:06:12 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604877, encodeId=d8d416048e755, content=<a href='/topic/show?id=42649836582' target=_blank style='color:#2F92EE;'>#院感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98365, encryptionId=42649836582, topicName=院感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003319278834, createdName=ms6390871039024434, createdTime=Sat May 09 13:06:12 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027970, encodeId=a02c102e970a9, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:06:12 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1653920, encodeId=067d1653920d1, content=<a href='/topic/show?id=6ca3533593e' target=_blank style='color:#2F92EE;'>#感染科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53359, encryptionId=6ca3533593e, topicName=感染科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d58c24405540, createdName=手留余香, createdTime=Mon Mar 08 13:06:12 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906517, encodeId=4a4d190651e1f, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58057, encryptionId=317e5805e9d, topicName=新冠患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Jun 06 12:06:12 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766545, encodeId=4e7e1e66545e8, content=<a href='/topic/show?id=bc80e48144f' target=_blank style='color:#2F92EE;'>#科主任#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74814, encryptionId=bc80e48144f, topicName=科主任)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f3637838032, createdName=446798725_87912777, createdTime=Sun Jul 05 12:06:12 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604877, encodeId=d8d416048e755, content=<a href='/topic/show?id=42649836582' target=_blank style='color:#2F92EE;'>#院感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98365, encryptionId=42649836582, topicName=院感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003319278834, createdName=ms6390871039024434, createdTime=Sat May 09 13:06:12 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027970, encodeId=a02c102e970a9, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:06:12 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
    2020-05-08 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

援鄂医生吴生华:上班前吃一桶泡面,曾一天诊治224名患者

“我们俩夫妻上班的时候,经常是十岁的女儿照顾两岁的儿子,习惯就好了。”从武汉回来后,吴生华聊得最多的,就是自己的两个孩子和还在护理一线工作的妻子。

北京市年龄较小患者均属在家庭确诊病例中被传染

1月31日,北京市新型冠状病毒感染的肺炎疫情防控工作新闻发布会上公布,本市出现的婴幼儿等年龄比较小的案例都与家庭中有确诊案例有关,年龄较小患者是在家庭中被传染。北京卫健委强调家庭中如有确诊病例后,其他家庭成员居家要格外注意,密切接触者要落实14天居家隔离,与家人接触双方戴口罩并有适当空间,相对安全距离是1.5米至2米。单独居住者每天要有2-3次通风,让新鲜空气流通,同时勤洗手,佩戴口罩,如果出现发

医护日记:看到患者从手都抬不起来到即将出院,无比欣慰

【编者按】2020年春节,寒风凛冽,病毒肆虐。万家灯火团圆之际,有一群人他们“逆行”向前,放弃假期,放下家庭,坚守在临床第一线。 他们心中只有一个目标:早日战胜疫情,守卫人民健康。从1月26日起,澎湃新闻浦江头条栏目推出《医护日记》,记录那些在临床一线为人民健康而战的医护人员。上海援鄂医疗队队员、金山区中西医结合医院呼吸科主治医师梁珀铭在武汉金银潭医院。 今天,由上海援鄂医疗队

Clinica Chimica Acta:类风湿性关节炎患者白蛋白与纤维蛋白原比值、c反应蛋白与白蛋白比值与Th17细胞的相关性研究

白蛋白与纤维蛋白原比值(AFR)和c反应蛋白与白蛋白比值(CAR)常被用作炎症标志物。然而,他们在RA中的作用仍不清楚。我们研究了RA中AFR/CAR与自身抗体和Th17细胞浓度的关系。

Clinica Chimica Acta:lncRNA可作2型糖尿病患者为诊断标志物?

为了筛选与葡萄糖激酶调节蛋白基因(GCKR)相关的长链非编码RNA (lncRNA),我们分析了在2型糖尿病(T2DM)患者和对照组中的差异表达。并验证lncRNA与GCKR的相关性,评估其作为T2DM分子标志物的潜在价值。

浙大一院39例确诊患者好转率56.4%,预计下周5例出院

澎湃新闻 2月1日从浙江省新型冠状病毒感染的肺炎疫情防控工作新闻发布会获悉,浙江大学医学院附属第一医院39名确诊病人中,有22例病情明显好转,好转率达56.4%,预计下周可能有5名患者达到出院标准,可以出院。 浙大一院专家、党委书记梁廷波在发布会上介绍,浙大一院之江院区集中收治新冠肺炎病人,床位800-1000张,收治重症病人床位60-100张。不同梯队的医护人员队伍已经组建成功,疫区医

Baidu
map
Baidu
map
Baidu
map